BSB I thought you and Umibe5690 bought some shares yesterday as GD sold his entire 1.5 million shares for 50k profit, because both of you appeared to be hunger for shares, and there came GD's shares.
I don't know why GD, the monkey king sold his shares, but if it was because LG's answer to IKE's list of questions, then that is a telling:
Most retail investors would be long gone when pps is in the range of $0.5 ~ 1, which would be a good thing because the ones support the share price higher than that would be new retails and institutions.
If one can read what an IR guy or lady has said literally, then a pig can climb up a tree.
If one has to find whether anything is new from LG yesterday's comments is the his deny of more than "a few" patients" out of completely randomized patient population, ie about 31 or so patients seem to out of the equation -- I guess he didn't lie but definitely there are stories behind the scene, and I guess it cannot be bad.
Just because the trial has yet to be unblinded doesn't prevents Linda from talking to FDA, submitting materials / applications to FDA, and even "corroborating" with FDA.
Perhaps, those 31 patients or so are involved; perhaps LG's stress that FDA's involvement in the partial halt is part of it; and perhaps by the time the trial is unblinded, the approval is already on the way to Linda's fax machine.
People are easy to forget that for FDA to approve a treatment, it needs to first check safety -- we have this checked, and then check efficacy -- judged by data reveled from two interim blended data releases I don't think our persons involved, including Linda P, and dr. Linda L, and of course Dr. B and the expert panel cannot find a way to prove it, if not outright approved by raw data in a simple computing in accordance with SAP.
A sudden unexpected 1.5 million sell didn't make a dent in share price yesterday in and of itself says something!
